Larbex® Steri-Neb

Budesonide, the active ingredient in Larbex® Steri-Neb, is a corticosteroid presented as an inhalation formulation for oral and inhaled use. It reduces airway inflammation and is employed in the management of asthma, chronic obstructive pulmonary disease, allergic rhinitis, and inflammatory bowel disease in adults and children.

GNH USA supplies Larbex® Steri-Neb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand consistently.

Budesonide is used in several respiratory and gastrointestinal conditions where inflammation plays a central role.

- Asthma: improves lung function and reduces frequency of exacerbations. - Chronic obstructive pulmonary disease (COPD): decreases airway inflammation and helps maintain airflow. - Allergic rhinitis: alleviates nasal congestion, itching and sneezing caused by allergic inflammation. - Inflammatory bowel disease (Crohn's disease, ulcerative colitis): induces remission by reducing intestinal mucosal inflammation.

Budesonide may cause a range of adverse reactions, from mild to serious, depending on dose and duration of therapy.

Common Side Effects: - Oral thrush: fungal infection of the mouth. - Hoarseness: voice changes after inhalation. - Cough: irritation of the airway.

Serious or Rare Side Effects: - Adrenal suppression: reduced endogenous cortisol production. - Pneumonia: increased risk of lower respiratory infection. - Severe allergic reaction: anaphylaxis or angioedema.

When prescribing budesonide, clinicians should consider several safety precautions to minimize risks.

- Assess infection risk: evaluate for active or latent infections before initiating therapy. - Monitor growth in children: regular height and weight checks are recommended. - Use spacer device: a spacer reduces oropharyngeal deposition during inhalation. - Avoid abrupt discontinuation: taper the dose to prevent adrenal insufficiency. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Budesonide can interact with other medicines that affect its metabolism or amplify its pharmacologic effects.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase systemic budesonide levels. - Ritonavir (HIV protease inhibitor): can markedly raise budesonide exposure.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin, phenytoin): may reduce therapeutic effectiveness. - Diuretics: may enhance hypokalemia when combined with systemic corticosteroid effects. - Anticholinergic bronchodilators: concurrent use may increase risk of dry mouth and throat irritation.